Chemoembolization for primary liver cancer

European Journal of Surgical Oncology

Volumn 28, Issue 1, 2002, Pages 37-41

  Achenbach, Tobias ^a   Seifert, J K ^b   Pitton, M B ^a   Schunk, K ^a   Junginger, T ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Chemoembolization; Response; Survival

Indexed keywords

IODINATED POPPYSEED OIL; MITOMYCIN C; ALPHA FETOPROTEIN; ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN;

ADULT; ARTICLE; CANCER SURVIVAL; CASE CONTROL STUDY; CHEMOEMBOLIZATION; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; HEMATOMA; HUMAN; LIVER ABSCESS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FAILURE; MORBIDITY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOSIS; AGED; BLOOD; FEMALE; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036484806     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1181     Document Type: Article

References (32)

1. Wittekind Ch, Tannapfel A. Pathologie der Lebertumoren. Chirurgische Gastroenterologie 1998; 14: 175-83.
2. Carr BI, Flickinger JC, Lotze MT. Hepatobiliary cancers. In: De Vita VT, Jr, Hellmann S, Rosenburg SA (ed.) Cancer - Principles and Practice of Oncology., 5th edn; 1997: 1087-1113.
3. Nakajima Y, Shimamura T, Kamiyama T, Kimura J, Sato N, Matsushita M, Une Y, Uchino J. Evaluation of surgical resection for small hepatocellular carcinomas. Am J Surg 1996; 171: 360-3.
4. Holbrook RF, Koo K, Ryan JA. Resection of malignant liver tumors. Am J Surg 1996; 171: 453-5.
5. Pirschel J, Lauchart W. Chemoembolisation primärer Leberkarzinome mit Epirubicin-Lipiodol. Fortschr Röntgenstr 1991; 155: 409-15.
6. Seifert JK, Junginger Th. Wiederholte Resektion bei primären und sekundären malignen Lebertumoren. Münchener Medizinische Wochenschrift 1995; 137: 622-6.
7. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Liver transplantation for hepatcellular carcinoma. World J Surg 1995; 19: 53-8.
8. Sugiura S, Takara K, Otho M, Okuda K, Hirooka N. Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 1983; 24: 920.
9. Zhou XD, Tang ZY, Yu YQ, Wenig JM, Ma ZC, Zhang BH, Zheng YX. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J Cancer Res Clin Oncol 1993; 120: 100-2.
10. Seifert K, Junginger Th, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998; 43: 141-54.
11. Vogl TJ, Müller PK, Mack MG, Straub R, Engelmann K, Neuhaus P. Therapiemöglichkeiten bei nicht resektablen Lebermetastasen. Perkutane radiologische Intervention. Chirurg 1999; 70: 133-40.
12. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999; 230: 1-8.
13. Yamada R, Sato M, Kawabato M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401.
14. Pavone P, Castrucci M, Catalano C, Marsili L, Petroni GA, Sanvito S, Salviani M. Effect of treatment on clinical trials: Chemoembolization. J Surg Oncol 1993; (Supp) 3: 87-90.
15. Galanski M, Schmoll E, Reichelt S, Böhmer G, Prokop M, Schäfer C, Schüler A, Ringe B, Schmidt FW, Schmoll HJ. Chemoembolisation hepatozellulärer Karzinome bei isoliertem Leberbefall. Radiologe 1992; 32: 49-55.
16. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
17. Ohnishi K, Tsuchiya S, Nakayama T, Hiyama Y, Iwama S, Goto N, Takashi M, Ohtsuki T, Kono K, Nakajima Y, et al. Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. Radiology 1984; 152: 51-5.
18. Bruix J, Llovet JM, Castells A, Montana X, Brú C, Ayuso M, Vilana R, Rodés J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-83.
19. Kawai S, Okamura J, Ogawa M, et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). Cancer Chemother Pharmacol 1992; 31 (Suppl. 1): 1-6.
20. Trubenbach J, Pereira PL, Huppert PE, Eul T, Konig CW, Duda SH, Claussen CD. Animal experiment studies on the effectiveness of permanent occlusion of the hepatic artery in transarterial chemoembolization. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2000; 172: 273-7.
21. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000; 88: 1574-81.
22. Kashima Y, Miyazaki M, Ito H, Kaiho T, Nakagawa K, Ambiru S, Shimizu H, Furuya S, Nakajima N. Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. Gastroenterol Hepatol 1999; 14: 922-7.
23. Rougier P, Roche A, Pelletier G, Ducreux M, Pignon JP, Etienne JP. Efficacy of chemoembolization for hepatocellular carcinomas: experience from the Gustave Roussy Institute and the Bicêtre Hospital. J Surg Oncol 1993; 3 (Suppl.): 94-6.
24. Gates J, Hartnell GG, Stuart KE, Clouse ME. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 1999; 19: 399-414.
25. Hashimoto T, Mitani T, Nakamura H, Hori S, Kozuka T, Kobayashi Y, Nakata A, Tsujimura T. Fatal septic complication of transcatheter chemoembolization for hepatocellular carcinoma. Cardiovascular Intervent Radiol 1993; 16: 325-7.
26. Trinchet JC, et al. (Groupe d'Etude et de Traitement du Cracinome Hépatocellulaire). A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. New Engl J Med 1995; 332: 1256-61.
27. Tarazov PG, Polysalov VN, Prozoroskij, Grishchenkova IV, Rozengauz EV. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol 2000; 41: 156-60.
28. Komatsu M, Fujii T, Goto T, Ohshima S, Nakane K, Yoneyama K, Ando H, Tanaka J, Hashimoto M. Giant hepatic biloma following transcatheter oily chemoembolization in a patient with hepatic metatases from malignant pheochromocytoma. Intern Med 1998; 37: 1034-8.
29. Reed RA, Teitelbaum GP, Daniels JR, Pentecost MJ, Katz MD. Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics. J Vasc Interv Radiol 1995; 6: 658-9.
30. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H. The long-term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82: 78-85.
31. Germer CT, Isbert C, Albrecht D, Roggan A, Pelz J, Ritz JP, Muller G, Buhr HJ. Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Ann Surg 1999; 230: 55-62.
32. Kouroumalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 1998; 42: 442-7.